Takeda denies rumors about effort to buy Alizyme

09/9/2008 | Bloomberg

Takeda Pharmaceutical said it has not made an offer to acquire Alizyme, but the drugmaker declined to discuss the possibility of future agreements with the British biotech firm. The statement came as market speculation surfaced on a takeover of Alizyme, which is already working with Takeda to develop weight-loss drug cetilistat.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ